Aberrant Promoter Hypermethylation of Mir34a and Mir200b Genes in Pediatric Acute Lymphoblastic Leukemia

Background: Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Epigenetic factors especially DNA methylation of promoter associated cytosine connected to guanine by phosphodiester bond (CpG islands) are considered as one of the most effective mechanisms in pathogenesis of ALL and have been demonstrated as a biomarker for lineage and subtype classification, prognostication, and disease progression. Objectives: In the present study, we examined the relationship between the promoter hypermethylation of the mir-200b and mir34a regulator genes on the Notch signaling pathway in patients with ALL and controls in order to investigate association between promoter hypermethylation and development, progression and clinical factors. Methods: Genomic DNA was extracted from 60 samples (30 blood samples from leukemia patients and 30 normal samples) and modified by sodium bisulfite. Methylation-specific PCR was used to analyze the promoter methylation status of mir-34a and mir200b genes in the studied population. The results were analyzed with SPSS software version 20. Results: Our results showed significant association of mir-200b (P < 0.0001) and mir-34a (P < 0.004) genes hypermethylation with ALL. Also there was significant relationship between hypermethylation of mir-200b gene with family history (P = 0.003) and platelets (P = 0.01), and methylation of mir-34a gene with cancer state (P = 0.003) and Hb (P = 0.001) in ALL. Conclusions: In this study, we emphasized the important role of epigenetics on acute lymphoblastic leukemia development and progression. Our results showed that analysis of the methylation status of mir200b and mir-34a genes can provide novel prognostic

• Publication year

  2019

• Venue

  Iranian Journal of Pediatrics

• Publication date

  2019-09-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.5812/ijp.89226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal microRNA expression in the course of hematological malignancies

  2018cited by this paper
• NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based Immunotherapies

  2018cited by this paper
• Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia

  2017cited by this paper
• MicroRNA expression and activity in T-cell acute lymphoblastic leukemia

  2017cited by this paper
• Members of the microRNA-200 family are promising therapeutic targets in cancer.

  2017cited by this paper
• Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL)

  2017cited by this paper
• Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts

  2017cited by this paper
• The co‐regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer

  2017cited by this paper
• Genetic abnormalities associated with acute lymphoblastic leukemia

  2016cited by this paper
• The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice

  2016cited by this paper
• Clinical significance of microRNAs in chronic and acute human leukemia

  2016cited by this paper
• Novel mechanisms of regulation of miRNAs in CLL.

  2016cited by this paper
• Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients.

  2016cited by this paper
• MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia

  2015cited by this paper
• The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach

  2015cited by this paper
• Methylation of miRNA genes and oncogenesis

  2015cited by this paper
• Epigenetic instability of imprinted genes in human cancers

  2015cited by this paper
• Genomic DNA Hypomethylation Is Associated with Neural Tube Defects Induced by Methotrexate Inhibition of Folate Metabolism

  2015cited by this paper
• Therapeutic strategies targeting cancer stem cells

  2015cited by this paper
• MiR-16 family as potential diagnostic biomarkers for cancer: a systematic review and meta-analysis.

  2015cited by this paper
• Mir-34: A New Weapon Against Cancer?

  2014cited by this paper
• Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer

  2014influential reference
• Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis

  2014cited by this paper
• IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

  2014cited by this paper
• Acute lymphoblastic leukaemia.

  2013cited by this paper
• Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey.

  2013cited by this paper
• MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

  2012cited by this paper
• Roles for microRNAs in conferring robustness to biological processes.

  2012cited by this paper
• Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

  2012cited by this paper
• Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein.

  2011cited by this paper
• Mechanisms of T cell development and transformation.

  2011cited by this paper
• Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis

  2011cited by this paper
• Notch Signaling in T-Cell Development and T-ALL

  2011cited by this paper
• Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer

  2011cited by this paper
• Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

  2011cited by this paper
• Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-κB Signaling Pathways

  2011cited by this paper
• Abstract 82: Expression of MUC17, a marker of pancreatic cancer, is under the control of epigenetic modifications

  2011cited by this paper
• The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells

  2011cited by this paper
• Epigenetic inactivation of the miR-34a in hematological malignancies.

  2010cited by this paper
• 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

  2010cited by this paper
• Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

  2010cited by this paper
• MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

  2009cited by this paper
• Monocyclic aromatic amines as potential human carcinogens: old is new again

  2009cited by this paper
• NSABP B-30: definitive analysis of quality of life (QOL) and menstrual history (MH) outcomes from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.

  2009cited by this paper
• Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia

  2007cited by this paper
• Methylation of Human MicroRNA Genes in Normal and Neoplastic Cells

  2007cited by this paper
• 5‐azacytidine in acute leukemia

  1978cited by this paper

• The comprehensive landscape of miR-34a in cancer research

  2021cites this paper